What is metabolic surgery and patient selection
DOI:
https://doi.org/10.47196/diab.v56i3Sup.568Keywords:
metabolic surgery, diabetes mellitusAbstract
Obesity (OB) is a chronic, relapsing, multicausal and multisystemic disease characterized by an abnormal/excessive accumulation of dysfunctional fat. Also is the main modifiable risk factor in the development of type 2 diabetes mellitus (T2D)1. The prevalence of both diseases is increasing rapidly and it is estimated that by 2045 there will be 783 million people with T2D2. This trend will be associated with increased mortality, cardiovascular risk and health costs. This has led to a constant search for therapeutic alternatives, and actually there are a lot of treatments for people with both diseases. These strategies include, low calories diet, medication and bariatric-metabolic surgery (BC); in all cases, the health team must carry out careful advice and develop personalized and multidisciplinary care plans.
Knowing the complex pathophysiology of T2D and its close link with OB, it factor must be taken into account when choosing T2DM treatment. As well as T2DM existence should be kept in mind when choosing OB treatment.
References
I. The Economic Impact of Overweight & Obesity in 8 Countries 4. Disponible en: https://data.worldobesity.org/publications/Economic-impact-overweight-obesity-in-countries-final.pdf
II. Diabetes around the world in 2021. Disponible en: https://diabetesatlas.org/
III. Consenso Intersocietario de Cirugía Bariátrica y Metabólica. Rev Argent Cirug 2021;113 (Suplemento 1):S1-S78.
IV. Aguirre-Ackermann M, Alva O, Álvarez MG, Andreoni M, Babor E, et al. Consenso Argentino de Cirugía Metabólica. Sociedad Argentina de Diabetes (SAD), Sociedad Argentina de Nutrición (SAN), Sociedad Argentina de Cirugía de la Obesidad (SACO). Revista de la Sociedad Argentina de Diabetes. 2015;49 (3):95-110.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
